V-Bio Ventures
Overview
V-Bio Ventures finds, builds and finances young companies with ambitions in the life sciences arena.
Investment Focus
- Differentiated technology addressing unmet needs
- High societal and/or environmental impact potential
- Focus on therapeutics, diagnostics supporting medical therapies, and sustainable agriculture
Portfolio Companies
Reach V-Bio Ventures directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about V-Bio Ventures
What sectors does V-Bio Ventures invest in?
V-Bio Ventures invests in Healthcare, Agriculture, HealthTech, Life Sciences, Pharmaceuticals and Medical Devices, and is based in Afsnee, Belgium. V-Bio Ventures is listed as a vc in the ConnectSafely investor database.
What stage does V-Bio Ventures invest at?
V-Bio Ventures backs companies at Seed and Early Stage.
Which regions does V-Bio Ventures invest in?
V-Bio Ventures invests across United Kingdom, Germany, France, Italy, Denmark and Switzerland.
Who are the partners at V-Bio Ventures?
Team members listed for V-Bio Ventures include Shelley Margetson (Managing Partner) and Willem Broekaert (Managing Partner).
What companies has V-Bio Ventures invested in?
V-Bio Ventures's portfolio includes Precirix, Sibylla Biotech, Augustine Therapeutics, Muna Therapeutics, BIODOL Therapeutics, Step Pharma, Confo Therapeutics and Corteria Pharmaceuticals.
How do I contact V-Bio Ventures?
V-Bio Ventures's contact details — including LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.
Last updated · Source: ConnectSafely investor database
